Healthcare & Pharmaceuticals

Russia says Sputnik Light 93.5% effective in Paraguay vaccination campaign

1 minute read

A medical specialist holds a vial of Sputnik V vaccine against the coronavirus in a department store in Moscow, Russia, January 18, 2021 REUTERS/Shamil Zhumatov/File Photo

MOSCOW, Aug 18 (Reuters) - Russia's single-dose Sputnik Light vaccine against COVID-19 has demonstrated 93.5% efficacy in Paraguay, with data taken from the South American country's vaccination campaign, the Russian Direct Investment Fund (RDIF) said on Wednesday.

Developed by Moscow's Gamaleya Institute, Sputnik Light had shown 79.4% efficacy when it was first authorised for use in May. read more

The RDIF, citing data from Paraguay's health ministry collected by July 30, said the vaccine had proved highly effective among more than 320,000 people.

"The use of the single-component vaccine Sputnik Light allows the Paraguayan authorities to shorten vaccination periods for the population and speed up the formation of collective immunity," RDIF head Kirill Dmitriev said in a statement.

Register now for FREE unlimited access to reuters.com
Reporting by Anton Kolodyazhnyy; Writing by Alexander Marrow, Editing by Timothy Heritage

Our Standards: The Thomson Reuters Trust Principles.

More from Reuters